HIV and AIDS News & Information

Criteria for Changing Therapy

Less than a 0.5–0.75 log reduction in plasma HIV RNA by 4 weeks following initiation of therapy, or less than a 1 log reduction by 8 weeks;
Failure to suppress plasma HIV RNA to undetectable levels within 4–6 months of initiating therapy.
Repeated detection of virus in plasma after initial suppression to undetectable levels, [...]

Table 7. Characteristics of nucleoside reverse transcriptase inhibitors (NRTIs)
Initiating Therapy in Advanced HIV Disease
All patients diagnosed with advanced HIV disease, which is defined as any AIDS-defining condition should be treated with antiretroviral agents regardless of plasma viral levels. All patients with symptomatic HIV infection without AIDS, defined as the presence of thrush or unexplained fever, [...]

Initiating Therapy in the Patient with Asymptomatic HIV Infection
Tables V and VI summarize the recommendations regarding when to initiate therapy and what regimens to use. In general, any patient with less than 500 CD4 + T cells/mm3 or greater than 10,000 (bDNA) or 20,000 (RT-PCR) copies of HIV RNA/ml of plasma should be offered therapy.
Table [...]

Antiretroviral treatment should be offered to all patients with the acute HIV syndrome, those within six months of seroconversion, and all patients with symptoms ascribed to HIV infection. Recommendations for offering antiretroviral therapy in asymptomatic patients depend on virologic and immunologic factors. In general, treatment should be offered to individuals with fewer than 300 CD4 [...]